Acute effect of L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure in obese men

Clinical Pharmacology and Therapeutics

Volumn 71, Issue 4, 2002, Pages 272-279

  Van Baak, Marleen A ^a,b,c,d   Hul, Gabby B J ^a,b,c   Toubro, Søren ^a,b,c   Astrup, Arne ^a,b,c   Gottesdiener, Keith M ^a,b,c   DeSmet, Marina ^a,b,c   Saris, Wim H M ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MERCK RESEARCH LABORATORIES   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; FATTY ACID; GLYCEROL; L 796568; N [4 [2 [[2 HYDROXY 2 (3 PYRIDINYL)ETHYL]AMINO]ETHYL]PHENYL] 4 [4 [4 (TRIFLUOROMETHYL)PHENYL]THIAZOL 2 YL]BENZENESULFONAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HEART RATE; HUMAN; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; SYSTOLIC BLOOD PRESSURE; TEMPERATURE MEASUREMENT; THERMOGENESIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; ANTI-OBESITY AGENTS; CROSS-OVER STUDIES; ENERGY METABOLISM; HUMANS; LIPOLYSIS; MIDDLE AGED; OBESITY; RECEPTORS, ADRENERGIC, BETA-3; SULFONAMIDES; THIAZOLES;

EID: 0036224375     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.122527     Document Type: Article

References (34)

1. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
2. Effect of sibutramine on weight maintenance after weight loss: A randomised trial
3. The peripheral sympathetic nervous system in human obesity
4. Role of α- and β-adrenoceptors in sympathetically mediated thermogenesis
5. 2-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization
6. 2-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men
7. β-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men
8. 3-adrenergic receptor mRNA in man
9. 3-adrenoceptor mRNA in human tissues
10. 3-adrenergic receptor mRNA in the human brain
11. 3-adrenoceptor in the human heart
12. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle
13. 3-adrenoceptor in man
14. 3-adrenoceptor mediated lipolysis in human fat cells
15. 3-adrenoceptor in man
16. 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
17. 3-adrenoceptor with low lipolytic action in human subcutaneous white adipocytes
18. 3-adrenoceptors mediate metabolic responses to isoprenaline
19. Adrenoceptor subtypes mediating catecholamine-induced thermogenesis in man
20. 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans
21. 3-adrenergic stimulation of human thermogenesis and lipid use
22. 3 adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-piridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4 (trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide
23. New methods for calculating metabolic rate with special reference to protein metabolism
24. Enzymatic and chemical extraction determinations of free fatty acids in serum compared
25. Determination of glycerol in plasma by an automated enzymatic spectrophotometric procedure
26. Measurement of leptin and leptin binding in the human circulation
27. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine
28. 3-adrenoceptor agonists in the treatment of obesity and diabetes
29. 3-adrenoceptor agonists in the treatment of obesity and diabetes
30. 3-adrenoceptor agonist in humans
31. 3-agonists, ZD7114 and ZD2079, on 24-hour energy expenditure and respiratory quotient in obese subjects
32. The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men
33. 3-adrenoceptors in the cardiovascular system